Definitive Contract 75N91022C00016
Award Date 9/15/22
Potential Completion Date 9/14/25
Potential Value $2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Champaign, IL 61820, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price SBIR Phase 1 contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Simbiosys Inc., a small disadvantaged business. The contract is for research and development of "Tools and Technologies for Visualizing Multi-Scale Data", under the NCI's broader SBIR program solicitation. The contract has a ceiling value of $400,000.00 and a period of performance ending on September 15, 2021. The contract was set aside...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Simbiosys Inc., a self-certified small disadvantaged business, for a Small Business Innovation Research (SBIR) Phase I project. The contract is for the SBIR PHASE I TOPIC #364: SIMBIOSYS ENVIRONMENT: A COMPUTATIONAL MICROSCOPE FOR CANCER MICROENVIRONMENTS, with a potential value of $211,535.00. The contract is a definitive, firm-fixed-price...
- This is a $1,997,803 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc., a small business manufacturer of specialized biomedical research equipment and tools. The contract is for the topic "Integrated Imaging and Molecular Analysis of Glioblastoma Using SCOPE SEQ on the Air Flow" and has a total small business set-aside designation. The contract will support...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
- This is a federal contract award by the National Cancer Institute (NCI), a civilian agency, to Sophic Systems Alliance Inc., a small business veteran-owned contractor. The contract is for a System to Analyze and Support Biomarker Research and Development Strategies under the Small Business Innovation Research (SBIR) Program Phase II. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a ceiling value of $745,999.90 and a period of performance ending on August...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Infotech Soft, Inc., a woman-owned small business. The contract, valued at $223,808.00, is for the development of a "Platform for High-Throughput Analysis of Integrated Cancer Imaging and Multi-Omics Data" under SBIR Topic #364. The contract is a Definitive Contract with a Firm Fixed Price...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...